−/− mice show evidence of sinus bradycardia and fragmented QRS complex, supporting the critical role of Slc26a6 in cardiac conduction system.
1 NBC mediates acid extrusion, whereas AE mediates acid loading.
Solute carrier Slc26a6 is a versatile anion exchanger, first identified in epithelial cells, with abundant expression in kidneys, pancreas, intestines, and placenta. [3] [4] [5] It mediates Cl − exchanger in the mouse heart, based on the transcript levels. 6 Our recent functional study identified 4 cardiac Slc26a6 isoforms, which mediate Cl − / HCO 3 − exchange in atrial and ventricular myocytes. 7 Importantly, we found that Cl − /HCO 3 − exchange by cardiac Slc26a6 is electrogenic. Indeed, cardiac Slc26a6 represents the first electrogenic exchanger with only
WHAT IS KNOWN?
• Intracellular pH (pH i ) is critical to cardiac excitation and contraction. Uncompensated changes in pH i impair cardiac function and trigger arrhythmias; however, cardiac pH i regulation mechanisms are not completely understood.
• Our previous studies identified several isoforms of a solute carrier, Slc26a6, to be highly expressed in mouse cardiomyocytes. We demonstrated that Slc26a6 mediates electrogenic Cl − /HCO 3 − exchange activities in cardiomyocytes supporting the role of Slc26a6 in the regulation of pH i and cardiac function.
WHAT THE STUDY ADDS?
• Ablation of Slc26a6 resulted in action potential shortening, reduced Ca 2+ transient and sarcoplasmic reticulum Ca 2+ load, decreased sarcomere shortening, and elevated pH i in mouse cardiomyocytes.
• At the in vivo level, Slc26a6 knockout mice showed reduced fractional shortening and cardiac contractility, as well as fragmented QRS complexes, supporting the critical roles of Slc26a6 in the regulation of cardiac excitability and contractility. 
MATERIALS AND METHODS
All animal care and procedures were performed in accordance with the protocols approved by Institutional Animal Care and Use Committee of the University of California, Davis, and in accordance with National Institutes of Health guidelines. De-identified human ventricular specimens were obtained from a commercial source, in accordance with the approved UC Davis Institutional Review Board protocol. Additional details are available in the Data Supplement.
We used 129S6/SvEv wild-type (WT) and Slc26a6 −/− mice previously generated and reported 8 (a generous gift from Dr Peter S. Aronson, Yale University) in our study. All experiments described in the study were conducted in a blinded fashion.
Cardiac Tissue Preparation and Cardiomyocyte Isolation
Mice were anesthetized by IP injection of 80 mg/kg of ketamine and 5 mg/kg of xylazine. Cardiomyocytes were isolated as described previously. 
Genotyping, Western Blot, and Histological Analyses
Histological and Western blot analyses of cardiac tissue were performed as we have described previously. 9 Genotyping analyses of Slc26a6 −/− mice are presented in Figure I in the Data Supplement.
Electrocardiographic Recordings
ECG recordings were performed as described previously.
10,11

Analysis of Cardiac Function by Echocardiography
Echocardiograms to assess systolic function were performed in conscious animals as we have described previously.
10
Hemodynamic Monitoring
Mice were anesthetized by IP injection of 80 mg/kg of ketamine and 5 mg/kg of xylazine and maintained at 37°C. Recording of pressure and volume was performed by using Millar Pressure-Volume System MPVS-300 (Millar, Inc, Houston, TX), Power Lab, and Lab Chart 6.0 software (AD Instruments, Colorado Springs, CO).
Patch-Clamp Recordings
Whole-cell current 7 and AP recordings 10 were performed as we have described previously. For current recordings, the clamped and suspended whole-cell was alternately exposed to theta capillary tubes dispensing control and test solutions at a potential of 0 mV. 7 For the outward current recording, we used the same solutions as we documented previously. 7 For the inward current recording, the pipette solution contained (in mmol/L): 24 NaHCO 3 , 116 Na glutamate, 1 EGTA, 1.4 NaCl, and gassed with 5% CO 2 
Measurement of Sarcomere Shortening and CaT
We used IonOptix sarcomere detection (IonOptix LLC, Westwood, MA) and the fast Fourier transform method. 12 Contraction was measured using a high-speed camera (MyoCam-S, 240-1000 frames/s) to record sarcomere movement. The sarcomere pattern was used to calculate the sarcomere length using a fast Fourier transform algorithm. The fractional shortening was calculated as the percentage change in sarcomere length during contraction. Simultaneous CaTs were recorded using Fura-2 dual-wavelength ratiometric method, 12 which is more precise than the Fluo-4 single-wavelength method.
The 
Molecular Cloning From Human Cardiac Tissues
Deidentified human ventricular specimens were obtained from a commercial source, in accordance with the approved UC Davis Institutional Review Board protocol. Total RNA and mRNA were extracted, and similar cloning strategy was used as described previously. 
Heterologous Expression in Chinese Hamster Ovary Cells
Human cardiac SLC26A6 isoforms were expressed in Chinese hamster ovary cells following the protocol we used previously.
7
Statistical Analyses
Data are presented as mean±SEM. Statistical comparisons were analyzed by Student t test. Statistical significance was considered to be achieved when P<0.05.
RESULTS
Ablation of Slc26a6 −/− Results in Cardiac AP Shortening
To test the functional roles of Slc26a6, we took advantage of an Slc26a6 −/− mouse model. 8 We first confirmed the lack of Slc26a6 expression in ventricular myocytes isolated from Slc26a6 −/− mice ( Figure 1A ). The 2 bands observed in WT lane suggest the different mouse cardiac slc26a6 isoforms we reported previously. 7 To test the role of Slc26a6 in Cl − /HCO 3 − and Cl − /oxalate exchange, we recorded outward currents using fast solution exchange and suspended whole-cell recording methods, as we have described previously.
7 Figure 1B Figure 1G ). APD shortening may also be caused by remodeling of other major ion channels such as Ca 2+ and K + channels from knockout of Slc26a6. Therefore, we recorded Ca 2+ and total K + currents from WT and Slc26a6 −/− ventricular myocytes. As shown in Figure II in the Data Supplement, there were no significant differences in the current density between WT and Slc26a6 −/− myocytes. 
Slc26a6
Roles of Slc26a6 in pH i Regulation
To test whether the Cl − /HCO 3 − exchange, mediated by Slc26a6, contributes to pH i regulation in ventricular myo-cytes, we directly measured the pH i of cardiomyocytes using SNARF-1 AM pH dye, as shown in Figure 3A and 3B. The pH i in resting Slc26a6 −/− cardiomyocytes was 7.42±0.02, significantly higher than that of 7.16±0.02 in WT cardiomyocytes. To test the function of Slc26a6 in acid loading, we first induced intracellular acidification by washin of 40 mmol/L acetate followed by an immediate washout and monitored the pH i recovery from alkalization. The pH i in WT cardiomyocytes recovered to the baseline level over time ( Figure 3C ), whereas there was a delay in the recovery of pH i in Slc26a6 −/− cardiomyocytes, over the same period of time ( Figure 3D) . The results suggested an impairment of the acidification process in Slc26a6 −/− cardiomyocytes and participation of Slc26a6 in the acid loading in cardiomyocytes.
We reason, based on its exchange activities, that Slc26a6 contributes to acid loading in cardiomyocytes under normal physiological conditions and that ablation of Slc26a6 may delay the acid-loading process and affect the sarcomere shortening and CaT. We perfused ventricular myocytes with a solution containing 40 mmol/L sodium acetate to acidify the cytosol and monitored the sarcomere shortening and CaT, as shown in Figure 3E . Acid loading resulted in marked reduction of sarcomere short- . The CaT was initially enhanced slightly and then inhibited by acetate-induced intracellular acidification. Moreover, after washout of acetate, the recovery process of sarcomere shortening and CaT was much slower in Slc26a6 −/− cardiomyocytes, consistent with Slc26a6 exchange activities (note that different scales are used for upper and lower panels). The immediate alkalization during the washout of acetate also inhibited contraction of the cardiomyocytes.
Decrease in Fractional Shortening in
The above cellular data strongly support the contributions of Slc26a6 to cardiac pH i , APD, and contractility. To test the effects of reduced CaT and sarcomere shortening in Slc26a6 −/− on in vivo cardiac function, we performed echocardiography in conscious mice. There was no evidence of cardiac hypertrophy or dilation, with no significant −/− cardiomyocytes show higher intracellular pH (pH i ). A, Measurement of pH i in ventricular myocytes by seminaphthorhodafluor-1, acetoxymethyl ester (SNARF-1 AM) using confocal microscopy (scale bar=10 μm). Loaded cells were excited by 488-nm laser, and images were acquired by using 2 band-pass filters with center wavelengths of 580 and 640 nm, respectively. The ratio of the emission signals at 580 and 640 nm was calculated and converted to pH value following the standard methods described before. [15] [16] [17] A bright field (BF) image of the cardiomyocyte was also shown at the lower panel. −/− ventricular myocytes. EIPA (5 µmol/L) was added to inhibit the Na + /H + exchanger during acetate application. The recovery process after washout of acetate for Slc26a6 −/− myocytes is much slower than that of WT myocytes. The black traces showed the CaT, and the blue traces showed the sarcomere length. Numbers within the bar graphs represent the sample sizes. stroke volume ( Figure 5B ). To determine the end-systolic P-V relationship, we obtained a series of P-V loops by altering the preload and derived the slope of the endsystolic P-V relationship (Ees), a load independent measure of cardiac contractility ( Figure 5C and 5D for WT and Slc26a6 −/− , respectively). Consistent with the cellular and echocardiography data, the end-systolic pressure (Figure 5E) , maximum dP/dt ( Figure 5F ), and Ees ( Figure 5G ) in Slc26a6 −/− mice were significantly reduced when compared with those of WT mice, supporting a decrease in cardiac contractility in Slc26a6 −/− mice. (Figures 1 and 3) . We, therefore, compared the ECG between WT and Slc26a6 −/− mice ( Figure 6A and 6B Figure 6C and 6D). Isoproterenol injection increased heart rates, but fragmented QRS complexes remained in Slc26a6 −/− mice. Summary data are shown in Figure 6E and 6F. Of note, even though the heart rate measured by echocardiography was significantly reduced in unanesthesized Slc26a6 −/− when compared with WT mice (Figure 4C ), only the PR intervals were significantly prolonged in the anesthetized Slc26a6 −/− mice during ECG recordings ( Figure 6E ). These in vivo findings suggest critical roles of Slc26a6 in cardiac conduction systems that warrant additional future investigations.
Fragmented QRS Complex in
Molecular Identification of Human Cardiac SLC26A6 Isoforms
Previous studies suggest that Cl − /oxalate exchange of mouse Slc26a6 is electrogenic, whereas the human SLC26A6 mediates electroneutral Cl − /oxalate exchange. 18, 19 To directly test whether there are indeed species differences, we performed RT-PCR to clone fulllength SLC26A6 from human heart (Figure 7) .
Six different transcript variants of human SLC26A6 have been described previously. During the cloning of human cardiac SLC26A6, 2 major transcript variants were repetitively obtained, suggesting the presence of alternatively spliced variants of SLC26A6 in human heart. We used a For-long and Rev primer set, as well as a For-short and Rev primer set ( Figure 7A) ; the PCR products are shown in Figure 7B . Twelve clones were randomly selected for each primer set, and the full-length sequence was confirmed by sequencing. Sequence analysis revealed that the 2 identified isoforms correspond to previously described transcript variant 2 (NM_134263. To test the function of the human cardiac SLC26A6, we expressed the human cardiac SLC26A6 isoforms in Chinese hamster ovary cells and recorded the current generated by the anion exchanger, using patch-clamp coupled with a fast solution exchange technique, as described in Figure 1B and 1G. Membrane potential was held at 0 mV. Figure 7C shows the outward currents generated by electrogenic Cl − /oxalate and Cl − / 
DISCUSSION
Slc26a6 has been proposed to be the predominant Cl − / HCO 3 − exchanger and a specific Cl − /OH − exchanger in the mouse heart, based on transcript levels. 6 Our group has since identified 4 cardiac Slc26a6 isoforms in the mouse heart, and importantly we demonstrated that mouse cardiac Slc26a6 mediates eletrogenic Cl − /HCO 3 − exchange activities in cardiac myocytes. 7 We predict, based on its electrogenic activities, that Slc26a6 may participate not only in the regulation of pH i , but also in cardiac excitability. To directly test this hypothesis, we took advantage of Slc26a6 −/− mice. Consistent with our prediction, ablation of Slc26a6 significantly shortens APD, resulting in reduced sarcomere shortening, CaT, and SR Ca 2+ load, in addition to an elevated pH i . Moreover, our in vivo studies demonstrate decreased fractional shortening and cardiac contractility, as well as sinus bradycardia in the knockout mice. Our results uncover new insights into the critical roles of cardiac electrogenic anion transporter-linking the regulation of not only pH i , but also cardiac excitability and contractility.
Roles of Bicarbonate in Cardiac pH Regulation
HCO 3 − /CO 2 buffer is the major component of the cellular pH buffering system. Bicarbonate is the byproduct of mitochondrial respiration; therefore, its concentration is highly affected by physiological and pathological conditions. HCO 3 − is critical for pH regulation, acid/ base secretion, and body fluid secretion. 20, 21 Although CO 2 can diffuse across the plasma membrane, HCO 3 − transport across the plasma membrane requires facilitation by HCO 3 − transporters and anion channels. HCO 3 − transporters are encoded by 14 genes belonging to SLC4A and SLC26A gene families. 20 The heart is an organ with a high metabolic rate, because of its continuous mechanical activities. Therefore, HCO 3 − is a critical anion in the regulation of cardiac function.
1,2 Unlike Na + , K + , and Ca 2+ ions, which directly affect the excitability and contractility of the heart, HCO 3 − participates in the regulation of cardiac function through its coupled transport with other cations and anions, as well as its direct control of cardiac pH. Therefore, it is a unique anion in the heart with dynamic regulation and a wide range of function. HCO 3 − participates in acid extruding and acid-loading processes in cardiomyocytes, which are coupled with Na + and Cl − transport, respectively. 1 Our studies provided strong evidence to support the role of Slc26a6 as an acid loader contributing to the acid-loading process in cardiomyocytes. Because cardiac Slc26a6 mediates Cl 
Electrogenic Properties of Human SLC26A6
In contrast to our current findings, previous studies suggest that human SLC26A6 may not be electrogenic. 18, 19 These studies, however, used an oocyte expression system and indirect measurement of changes in reversal potentials, wherein intracellular ion concentrations were unknown and could not be precisely controlled during the recordings. In contrast, we used patch-clamp recordings with fast solution exchange to precisely set the ionic gradient across the plasma membrane and monitor the dynamic changes of the currents. We observed electrogenic Cl − /HCO 3 − and Cl − /oxalate exchange activities of both mouse and human cardiac SLC26A6 (Figure 7 ).
Critical Roles of Electrogenic Transporters in Cardiac Excitability
Electrogenic transporters contribute significantly to cardiac excitability. The well-described Na + /K + pump contributes to the generation of resting membrane potentials and repolarization of cardiac APs. 22 tration in cardiomyocytes. Here, we directly monitored the acidification process during the application and washout of acetate. Slc26a6 −/− cardiomyocytes show delayed acidification, supporting the role of Slc26a6 in cellular acid loading (Figure 3) .
In addition to Slc26a6, it has been reported that Slc4a families are expressed in cardiomyocytes, including AE1 (Slc4a1), AE2 (Slc4a2), and AE3 (Slc4a3), which are acid loaders. Other Slc4a members are mostly Na + /HCO 3 − cotransporters, mediating acid extrusion. 1, 6 However, the expression levels of AE1, AE2, AE3, and Slc26a3 are relatively low when compared with Slc26a6. 6 Nonetheless, it is possible that there is compensation from AE and other Slc26a families during the pH i recovery process. The dominant molecule for acid loading is Slc26a6 because its expression level is nearly 100-fold higher than that of AEs and Slc26a3.
Decreased Cardiac Contractility in Slc26a6
−/− Mice
The shortened cardiac APs are predicted to decrease Ca 2+ influx through L-type Ca 2+ channels, leading to reduced CaT and sarcomere fractional shortening in Slc26a6 −/− cardiomyocytes. Additionally, the elevated pH i may contribute to changes in CaT and contractility. Indeed, pH i is a critical regulator of cardiac ion channels and transporters, as well as other membrane and contractile proteins and, therefore, exerts significant influences on cardiac Ca 2+ signaling, contractility, and excitability.
1,2 Effects of acidosis on cardiac function have been extensively investigated because of its pathological significance during ischemia-reperfusion. [27] [28] [29] [30] [31] [32] [33] [34] Cellular acidification reduces CaT and contraction in cardiomyocytes. 1, 27, 29, 31, 35 Our results showed that CaT was initially enhanced and later inhibited by cellular acidification, induced by washin of acetate ( Figure 3E) when Na + /H + exchanger was inhibited, similar to that observed by Vaughan-Jones et al. 1 The reduced sarcomere shortening observed in our study from acidification ( Figure 3E ) agrees with previously reported findings.
On the other hand, effects of intracellular alkalization on cardiac contractility and CaT are less understood. Our findings in Figure 3E demonstrate that acid loading had a relatively small influence on CaT compared with cell shortening in both WT and Slc26a6 −/− myocytes, however, alkalization during washout dramatically decreased CaT and cell shortening. The findings suggest that lower pH i had a minor effect on CaT but may affect the Ca 2+ affinity of troponin C. 1 Taken together, the impairment of cardiac contractility in Slc26a6 −/− mice is likely due to multiple mechanisms, including alterations in pH i , in addition to reduced APDs, CaT, and SR Ca 2+ load.
Future Studies
One previous study using a different strain of Slc26a6 −/− mice reported normal body weight, heart rate, and blood pressure in Slc26a6 −/− mice. 36 Our studies demonstrate comparable heart/body weight ratio between WT and Slc26a6 −/− mice; however, there is evidence of sinus bradycardia and fragmented QRS complex in Slc26a6 −/− mice with prolonged PR interval. Fragmented QRS complexes have been shown to be common in patients post-myocardial infarction; they may represent a marker for cardiovascular diseases [37] [38] [39] and predict arrhythmic events and mortality in patients with cardiomyopathy. 40, 41 Fragmented QRS was also reported to be prognostically significant in patients with Brugada syndrome, supporting the association of fragmented QRS and arrhythmia substrate. 42 Slc26a6 −/− mice showed sinus bradycardia and fragmented QRS; however, there is no significant cardiac fibrosis in Slc26a6 −/− mice. 43 Therefore, we expect a spectrum of cellular proteins that need to be further evaluated. However, these extensive investigations will be performed in our future experiments.
The global knockout of Slc26a6 was reported to affect the kidney and duodenum epithelial transport 36 and induce Ca 2+ oxalate urolithiasis. 8 The alteration in metabolic profiles in Slc26a6 −/− may affect the observed in vivo cardiac function. Therefore, we took advantage of not only in vivo physiological measurement, but also in vitro analyses in our studies to circumvent these possible confounding factors. Indeed, our in vivo findings are consistent with in vitro analyses.
In conclusion, the current study unravels novel mechanistic insights into the newly described and unique cardiac electrogenic Cl − /HCO 3 − transporter in ventricular myocytes. Activities of Slc26a6 contribute to not only the regulation of pH i , but also cardiac AP and contractility. Ablation of Slc26a6 shortens the APDs, impairs cardiac function, and results in fragmented QRS complexes and elevated pH i . Additional studies are required to further understand the functional roles of Slc26a6 not only in ventricular myocytes, but also in pacemaking cells and the cardiac conduction system. 
